Literature DB >> 1744457

[Prenatal diagnosis of carbamyl phosphate synthetase deficiency by fetal liver biopsy].

J Murotsuki1, S Uehara, K Okamura, A Yajima, M Kikuchi, T Oura, S Miyabayashi.   

Abstract

Carbamyl phosphate synthetase deficiency (CPSD) is one of the enzyme defects of the urea cycle and inherited as an autosomal recessive. A definitive enzymatic diagnosis of CPSD can be made by biochemical assay of liver biopsy material, but not of cultured fibroblasts. In pregnancy at risk for CPSD, prenatal diagnosis was attempted by fetal liver biopsy, performed at 22 weeks of gestation. CPS activity was present and a healthy baby was delivered at term. The technique employed for fetal liver biopsy is described together with an evaluation of its possible role in prenatal diagnosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744457

Source DB:  PubMed          Journal:  Nihon Sanka Fujinka Gakkai Zasshi        ISSN: 0300-9165


  2 in total

Review 1.  Fetal tissue sampling--indications, techniques, complications, and experience with sampling of fetal skin, liver, and muscle.

Authors:  C Cadrin; M S Golbus
Journal:  West J Med       Date:  1993-09

2.  Carbamyl phosphate synthetase I deficiency. One base substitution in an exon of the CPS I gene causes a 9-basepair deletion due to aberrant splicing.

Authors:  R Hoshide; T Matsuura; Y Haraguchi; F Endo; M Yoshinaga; I Matsuda
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.